170784 ⎘
Screening for compounds of potential therapeutic value Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Method of treating cancer with modulators of SCFSkp2
#602Hydrolases, nucleic acids encoding them and methods for making and using them
#603Method for treating ocular cancer
#604Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
#605High-affinity monoclonal anti-prion antibodies
#606Method of screening for chaperonin modulator
#607MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
#608Neuregulin variants and methods of screening and using thereof
#609Methods and compositions for gamma-secretase assay
#610Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#611Cinnamoyl inhibitors of transglutaminase
#612Sequence-specific extraction and analysis of DNA-bound proteins
#613Treatment and prevention of malaria
#614Process for treating an individual with an esthetic defect of skin by modulating SASPase FLG2 complex
#615Selective glycosidase inhibitors and uses thereof
#616Agonistic antibodies to TrkC receptors and uses thereof
#617Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase
#618Peptides that modulate complex SASPase-FLG2
#619Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists
#620Treatment of penetrative injury to the brain
#621Methods of treating neurodegenerative disease
#622Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin
#623Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus
#624SIR2 regulation
#625Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
#626Methods for selective targeting
#627Methods of identifying insect-TRPA1 modulators
#628Use of a growth-stimulating protein
#629Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
#630Inhibitor of HMGB protein-mediated immune response activation, and screening method
#631Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#632Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#633Enzyme regulating ether lipid signaling pathways
#634Compositions and methods for treating cancer and modulating stress granule formation
#635Specific binding sites in collagen for integrins and use thereof
#636HIFα hydroxylation assay
#637Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
#638Inhibitors of influenza endonuclease activity and tools for their discovery
#639Tools for the identification of Lingo-1, Lingo-2, Lingo-3 and Lingo-4 ligands, and uses thereof
#640Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases
#641COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND NEUTROPENIA
#642Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof
#643Inhibitors of mitochondrial fission and methods of use thereof
#644CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#645Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
#646Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#647Serology assays
#648METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONS
#649Methods for identifying allosteric and other novel acyl-coenzyme A:cholesterol acyltransferase inhibitors
#650METHODS OF SUPPRESSING CANCER, INCREASING WEIGHT LOSS AND/OR INCREASING INSULIN SENSITIVITY
#651Method and means for identifying substances which inhibit IgE production
#652INHIBITORS OF GALECTIN-3 AND METHODS OF USE THEREOF
#653Screening method for an insulin resistance improving agent or a therapeutic agent for diabetes
#654ASSAYS AND METHODS PERTAINING TO PRE-AMYLOID INTERMEDIATES
#655SCREENING METHOD
#656Arrays Of Biological Membranes And Methods And Use Thereof
#657Ovary tumor markers and methods of use thereof
#658BRAF mutations conferring resistance to BRAF inhibitors
#659Enhancement of vanadium-containing phosphatase inhibitors
#660Methods of inhibiting staphylobactin-mediated iron uptake in
#661Dual activity kinase domains and uses thereof
#662METHODS FOR TREATING DISEASES
#663FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#664MULTIPROTEIN ASSEMBLIES
#665COMPOUND CAPABLE OF BINDING TO NATURALLY OCCURRING DENATURED PROTEIN, AND METHOD FOR SCREENING FOR THE COMPOUND
#666METHODS AND COMPOSITIONS FOR CANCER TREATMENT RELATING TO BRCA1 BRCT DOMAIN RECOGNITION OF PHOSPHORYLATED BACH1
#667Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
#668Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
#669Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors
#670ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE
#671Methods and compositions for mycoplasma pneumoniae exotoxins
#672TEST SYSTEM FOR MEASURING MEST ACTIVITY AS WELL AS METHODS AND USES INVOLVING THE SAME
#673METHODS FOR THE IDENTIFICATION OF KINASE INTERACTING MOLECULES AND FOR THE PURIFICATION OF KINASE PROTEINS
#674Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
#675METHOD FOR SCREENING OSTEOPONTIN INHIBITOR AND INHIBITOR OBTAINED FROM THE METHOD
#676Methods for diagnosis and treatment of endometrial cancer
#677Antichlamydial agents
#678RECEPTORS OF RSPO2 AND RSPO3
#679Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
#680Treatment of renal disease
#681Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4
#682Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#683Biglycan and related therapeutics and methods of use
#684Method for screening of therapeutic agent for hyperlipemia
#685IDENTIFICATION OF MODULATORS OF SERINE PROTEASE INHIBITOR KAZAL AND THEIR USE AS ANTI-CANCER AND ANTI-VIRAL AGENTS
#686MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION
#687Compositions and methods for treatment of eye disorders
#688Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity
#689Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#690GENE AND POLYPEPTIDE RELATING TO BREAST CANCER
#691Compositions and methods for identifying response targets and treating flavivirus infection responses
#692SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF
#693Method and compositions for treating stroke with fever
#694Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#695Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
#696Fragment ligated inhibitors selective for the polo box domain of PLK1
#697Method for insulin resistance improving and a method for prevention or treatment of diabetes
#698CORE 2GLCNAC-T INHIBITORS
#699ENHANCED SUBSTRATES FOR THE PROTEASE ACTIVITY OF SEROTYPE A BOTULINUM NEUROTOXIN
#700HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
#701Heparin-insensitive method for determining direct coagulation factor inhibitors
#702Method for identifying modulators of GPCR GPR1 function
#703USE OF BINDING PARTNERS FOR 5-HT5 RECEPTORS FOR THE TREATMENT OF NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS
#704IAP BIR domain binding compounds
#705Monocot seed product comprising a human blood protein
#706RAF DIMERS AND USES THEREOF
#707Compositions and Methods for Modulation of Bone Density and Biomineralization
#708Modulation of miRNA Activity
#709T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAME
#710METHODS FOR THE IDENTIFICATION OF ZAP-70 INTERACTING MOLECULES AND FOR THE PURIFICATION OF ZAP-70
#711METHODS OF TREATMENT USING AN ANTI IL B50 ANTIBODY
#712AFFINITY CAPILLARY ELECTROPHORESIS METHOD FOR ASSESSING A BIOLOGICAL INTERACTION OF A LIGAND/RECEPTOR PAIR SUCH AS G PROTEIN COUPLED RECEPTOR AND ITS TARGETS AS WELL AS FOR DRUG SCREENING
#713Compositions and methods for identifying enzyme and transport protein inhibitors
#714Methods and compositions involving nucleotide repeat disorders
#715Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
#716Fatty acid binding proteins as drug targets for endocannabinoids
#717THREE-DIMENSIONAL STRUCTURES OF TALL-1 AND ITS COGNATE RECEPTORS AND MODIFIED PROTEINS AND METHODS RELATED THERETO
#718METHODS AND KITS FOR MEASURING ENZYME ACTIVITY
#719USP47 inhibitors and methods to induce apoptosis
#720Protein fragment complementation assays for high-throughput and high-content screening
#721Polypeptides for the in vitro assessment of the sensitising potential of a test compound
#722MUTANT RAS POLYPEPTIDE CRYSTAL
#723NOVEL BAK BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF
#724Compositions and Methods for Modulating the Immune Response and Identifying Immunomodulators
#725METHODS FOR MODULATING TOLL-LIKE RECEPTOR MEDIATED ACTIVATION OF CELLS OF THE INNATE SYSTEM BY MODULATING XBP-1 ACTIVITY
#726Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation
#727Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
#728Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders
#729Therapeutic agents for alzheimer's disease and cancer
#730METHOD FOR TREATING CANCER BY INCREASING AMP-ACTIVATED KINASE ACTIVITY
#731Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#732Interferon-lambda 1 polypeptides
#733Compositions and Methods for Modulating Immunodeficiency Virus Transcription
#734Polypeptide Fragments Comprising Endonuclease Activity and Their Use
#735Disrupting FCRN-albumin interactions
#736Modified defensins and their use
#737Inhibitors of viral integrase and methods of use
#738Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
#739SELECTING FOR COOPERATIVELY INTERACTING MOLECULES
#740Agents for treatment of HCV and methods of use
#741Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof
#742CRYSTAL STRUCTURE
#743METHODS FOR THE IDENTIFICATION OF KINASE INTERACTING MOLECULES AND FOR THE PURIFICATION OF KINASE PROTEINS
#744PARKIN SUBSTRATE AND ASSAY
#745Insulin-like growth factor signaling and integrin
#746Modulation of activity of neurotrophins
#747Methods for modulating neuronal responses
#748Use of a growth-stimulating protein
#749APOBEC3 MEDIATED DNA EDITING
#750MITOCHONDRIAL LOCALIZATION OF MUC1
#751METHOD, COMPOSITION AND KIT FOR ANTIGENIC BINDING OF NORWALK-LIKE VIRUSES
#752DBC1, A NOVEL NATIVE INHIBITOR OF THE ANTI-AGING PROTEIN SIRT1
#753Antibodies that bind stresscopin peptides
#754Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#755Antibodies to signal transduction protein TAB2
#756HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON
#757METHOD
#758METHODS OF DIAGNOSING CERVICAL CANCER
#759MIF antagonists
#760Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies
#761Methods of treatment using antibodies to Neutrokine-alpha
#762IDENTIFICATION OF SORTILIN AS A NEURONAL RECEPTOR FOR THE FRONTOTEMPORAL DEMENTIA PROTEIN, PROGRANULIN
#763IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMER
#764Screening systems utilizing RTP801
#765TFPI inhibitors and methods of use
#766Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds
#767MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#768Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation
#769Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban
#770DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION
#771METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS
#772Chimeric RGMa polypeptides
#773IL-1F5 polypeptides
#774METHOD TO ASSAY PHOSPHOLIPID AND TRIGLYCERIDE TRANSFER ACTIVITY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN
#775Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
#776Enigma-Mdm2 interaction and uses thereof
#777METHODS OF MODULATING CELL DEATH BASED ON THE BIT1/AES REGULATORY PATHWAY
#778METHOD FOR DETECTION OF AN ENZYME-SUBSTRATE REACTION
#779ENRICHMENT AND PURIFICATION OF INFECTIOUS PRION PROTEINS
#780ELECTROPHORETIC TAG-BASED IN VITRO ASSAY TO QUANTIFY DIMERIZATION OF P66 AND P51 SUB-UNITS OF HIV-1 REVERSE TRANSCRIPTASE (RT)
#781Compositions and Methods to Treat Bone Related Disorders
#782Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#783PRPK-TPRKB modulators and uses thereof
#784COMPOSITIONS, KITS AND METHODS FOR DETERMINING PLASMIN ACTIVITY
#785Compounds having an isolated peptide consisting of structure (I)
#786Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
#787Method for treating a disorder associated with Eya dysregulation by modulating Eya phosphatase activity
#788Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
#789METHOD AND COMPOSITIONS FOR DETERMINING ENZYMATIC ACTIVITY AND SPECIFICITY OF METHYLTRANSFERASES
#790Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#791Homogeneous activity test for determining enzymatic reactions
#792COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
#793METHODS FOR SCREENING FOR HISTONE DEACETYLASE ACTIVITY AND FOR IDENTIFYING HISTONE DEACETYLASE INHIBITORS
#794Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1
#795Vaccinia virus protein A46 peptide and use thereof
#796METHOD FOR MODULATING MUSCLE DIFFERENTIATION OR REGENERATION
#797METHODS AND COMPOSITIONS FOR THE REGULATION OF LECTIN COMPLEMENT PATHWAY (LCP)-ASSOCIATED COMPLEMENT ACTIVATION IN HYPERGLYCEMIC MYOCARDIAL DAMAGE
#798Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPase
#799Human T2R receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators
#800METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE REGULATION OF IRON RESPONSE ELEMENTS
#801Protein-based assays for screening of the IgE-receptor interaction
#802Preventing and treating sepsis
#803Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders
#804Screening methods
#805Carbohydrate binding molecules
#806SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING USING LIGHT SCATTERING
#807SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX
#808Construction and crystallization of expression system for RNA polymerase PB1-PB2 protein derived from influenza virus
#809Cyclin based inhibitors of CDK2 and CDK4
#810GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#811IDENTIFYING PARATHYROID HORMONE AGONISTS AND ANTAGONISTS
#812Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1
#813ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
#814BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#815Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices
#816Insecticidal compounds and methods for selection thereof
#817Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#818Inhibition of DNA polymerases to augment chemotherapeutic and antimicrobial agents
#819Discovery and applications of the proteolytic function of N-terminal acetylation of cellular proteins
#820INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA
#821Methods for selecting protease resistant polypeptides
#822Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds
#823COMPOSITIONS AND METHODS FOR MODULATING CELLS VIA CD14 AND TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY
#824Methods for the early diagnosis of ovarian cancer
#825NEUREGULIN/ERBB SIGNALING AND INTEGRIN
#826MUC1, caspase-8, and DED-containing proteins
#827SCREENING ASSAYS FOR INHIBITORS OF A STAPHYLOCOCCUS AUREUS SIDEROPHORE
#828Ivermectin antagonizes ethanol inhibition in P2X4 receptors
#829Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
#830NEW TREATMENT OF AUTOIMMUNE CONDITIONS
#831Methods and compositions for identifying inhibitors of MutSα or MutSβ interaction with MutLα
#832Nucleic acids encoding RUP3 and methods of using same
#833Methods of treating a meiotic kinesin associated disease
#834CELL LINES AND HOST NUCLEIC ACID SEQUENCES RELATED TO INFECTIOUS DISEASE
#835MARKER SEQUENCE FOR NEURODEGENERATIVE DISEASES AND THE USE THEREOF
#836FULL LENGTH LARGE T TUMOR ANTIGEN OF MERKEL CELL POLYOMAVIRUS AS A THERAPEUTIC TARGET IN MERKEL CELL CARCINOMA
#837NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#838SIR2 regulation
#839METHODS OF TREATMENT USING BIASED LIGANDS FOR RECEPTORS SUCH AS THE PTH RECEPTOR
#840Enhancement of vanadium-containing phosphatase inhibitors
#841PSA AND KLK2 AS THERAPEUTIC TARGETS AND MOLECULES INHIBITING PSA AND KLK2
#842METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#843Compounds For Treating Human Papillomavirus
#844Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins
#845METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN
#846IFN-ALPHA/BETA-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION THROUGH A NOVEL LIGAND-RECEPTOR PAIR: IFN- LIGANDS ENGAGE A NOVEL RECEPTOR IFN-RN (CRF2-12) AND IL-10R2 (CRF2-4) FOR SIGNALING ANDINDUCTION OF BIOLOGICAL ACTIVITIES
#847Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
#848EMISSION RATIOMETRIC INDICATORS OF PHOSPHOINOSITIDES
#849Methods and compositions for treating alzheimer's disease
#850Compositions and methods for treatment
#851Compositions and methods for treatment
#852Therapeutic agents for alzheimer's disease and cancer
#853Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof
#854Compositions and methods for the treatment of cancer
#855Compositions and Methods for Increasing Bone Mineralization
#856MODULATORS OF CARNITINE OCTANOYLTRANSFERASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#857GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#858Use of a TAS2R7 nucleic acid sequence to identify modulators
#859FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS
#860SELECTIVITY PROFILING OF PI3K INTERACTING MOLECULES AGAINST MULTIPLE TARGETS
#861Kit for assaying EphA4 processing by gamma-secretase
#862Method of bioassaying yokukansan
#863Compositions comprising solanum tuberosum for lowering cytosolic NADH level to mimic calorie restriction
#864Methods and compounds useful to induce apoptosis in cancer cells
#865Modulation of Adenoviral Tropism
#866C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS
#867Soluble notch-based substrates for gamma secretase and methods and compositions for using same
#868MODULATORS OF STAT3 SIGNALLING
#869Peptides and methods of use as therapeutics and screening agents
#870COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION
#871Thioredoxin interacting protein (TXNIP) as regulator of vascular function
#872METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX
#873DRUG SAFETY TEST USING PENTRAXIN-3 (PTX-3)
#874Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
#875ANTI-PSGL-1 INHIBITORS AND SCREENING METHODS
#876Assay methods for identifying glycogen synthase kinase 3 modulators
#877B7 family member zB7H6 and related compositions and methods
#878Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
#879CARDIOVASCULAR SAFETY ASSAY
#880Cancer cell migration and cancer cell invasion inhibitor
#881Methods for Assessing CDK5 Activation and Function
#882NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#883Methods of treating a family viral infection and compositions for treating a family viral infection
#884Screening systems utilizing RTP801
#885COPI MOLECULES AND USES THEREOF
#886METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION
#887METHOD FOR THE IDENTIFICATION OF PATIENTS IN NEED OF THERAPY HAVING MINOR COGNITIVE DISORDERS AND THE TREATMENT OF SUCH PATIENTS
#888Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′ UTR of SUB2 and the SUB2 serine protease
#889PARASPORIN-1 RECEPTOR AND USE THEREOF
#890Modulation of T cell signaling threshold and T cell sensitivity to antigens
#891Methods and compositions involving nucleotide repeat disorders
#892Methods of making an antibody that binds a chemerin polypeptide
#893METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
#894AGENTS FOR STIMULATING ACTIVITY OF METHYL MODIFYING ENZYMES AND METHODS OF USE THEREOF
#895Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#896METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
#897HIGH THROUGHPUT PROTEIN INTERACTION ASSAY
#898Identification of astrovirus VA1 associated with gastroenteritis in humans
#899MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN
#900Modulators of ATP-binding cassette transporters